STAT3 and glioblastoma: The small molecule inhibitor of STAT3, LLL12, has previously been shown to inhibit cellular proliferation and migration in several human malignant breast, pancreas and glioblastoma cells lines (IC50 concentrations ranging from 0.16–3.09 μM) [14], however inhibition of angiogenesis by this compound has not been investigated.